Parabilis Medicines, Inc.
PBLSNasdaqCIK 1657677HealthcareFiscal year ends Dec 31
Reports and events: 11 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1516:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-391952 |
| 2026-09-0216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-380171 |
| 2026-08-2516:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-365132 |
| 2026-08-1316:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349168 |
| 2026-08-1307:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347869 |
| 2026-06-1816:09 ET | SCHEDULE 13D | Ownership report, active investor | 0001346824-26-000178 |
| 2026-06-1116:12 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-267550 |
| 2026-06-0906:09 ET | S-1/A | Registration statement, amended | 0001193125-26-262880 |
| 2026-06-0406:16 ET | S-1/A | Registration statement, amended | 0001193125-26-256398 |
| 2026-05-2716:55 ET | S-1/A | Registration statement, amended | 0001193125-26-242067 |
| 2026-05-1916:53 ET | S-1 | Registration statement | 0001193125-26-230994 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.